Expression and site-specific mutagenesis of the poliovirus 3C protease in Escherichia coli.

PubWeight™: 1.76‹?› | Rank: Top 3%

🔗 View Article (PMC 386292)

Published in Proc Natl Acad Sci U S A on August 01, 1986

Authors

L A Ivanoff, T Towatari, J Ray, B D Korant, S R Petteway

Articles citing this

Molecular and biotechnological aspects of microbial proteases. Microbiol Mol Biol Rev (1998) 4.84

Viral cysteine proteases are homologous to the trypsin-like family of serine proteases: structural and functional implications. Proc Natl Acad Sci U S A (1988) 4.32

Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. Proc Natl Acad Sci U S A (1990) 4.12

Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes. Microbiol Rev (1993) 3.33

Poliovirus proteinase 3C: large-scale expression, purification, and specific cleavage activity on natural and synthetic substrates in vitro. J Virol (1988) 2.09

Two novel heat shock genes encoding proteins produced in response to heterologous protein expression in Escherichia coli. J Bacteriol (1992) 1.98

Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell-free system from clone-derived transcripts. J Virol (1987) 1.77

Expression of tetanus toxin fragment C in E. coli: high level expression by removing rare codons. Nucleic Acids Res (1989) 1.75

The refined crystal structure of the 3C gene product from hepatitis A virus: specific proteinase activity and RNA recognition. J Virol (1997) 1.68

Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3. J Virol (1990) 1.54

Substitution of cysteine 192 in a highly conserved Streptococcus pyogenes extracellular cysteine protease (interleukin 1beta convertase) alters proteolytic activity and ablates zymogen processing. Infect Immun (1996) 1.52

Effects of mutations in poliovirus 3Dpol on RNA polymerase activity and on polyprotein cleavage. J Virol (1989) 1.48

Identification and characterization of a 3C-like protease from rabbit hemorrhagic disease virus, a calicivirus. J Virol (1994) 1.48

Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection. J Virol (1991) 1.40

Cleavage of small peptides in vitro by human rhinovirus 14 3C protease expressed in Escherichia coli. J Virol (1989) 1.38

trans rescue of a mutant poliovirus RNA polymerase function. J Virol (1991) 1.35

A norovirus protease structure provides insights into active and substrate binding site integrity. J Virol (2005) 1.34

Expression of enzymatically active poliovirus RNA-dependent RNA polymerase in Escherichia coli. Proc Natl Acad Sci U S A (1987) 1.24

Poliovirus thiol proteinase 3C can utilize a serine nucleophile within the putative catalytic triad. Proc Natl Acad Sci U S A (1991) 1.20

Chimeric picornavirus polyproteins demonstrate a common 3C proteinase substrate specificity. J Virol (1989) 1.15

Proteolytic activity of hepatitis A virus 3C protein. J Virol (1991) 1.15

Identification of active-site amino acid residues in the Chiba virus 3C-like protease. J Virol (2002) 1.14

The picornaviral 3C proteinases: cysteine nucleophiles in serine proteinase folds. Protein Sci (1995) 1.07

A rapid method for determination of endoproteinase substrate specificity: specificity of the 3C proteinase from hepatitis A virus. Proc Natl Acad Sci U S A (1991) 1.07

Regulation of poliovirus 3C protease by the 2C polypeptide. J Virol (2004) 0.91

cis- and trans-cleavage activities of poliovirus 2A protease expressed in Escherichia coli. J Virol (1991) 0.90

Novel bacteriological assay for detection of potential antiviral agents. Antimicrob Agents Chemother (1990) 0.83

Identification of active-site residues in protease 3C of hepatitis A virus by site-directed mutagenesis. J Virol (1997) 0.81

Characterization of Bafinivirus main protease autoprocessing activities. J Virol (2010) 0.78

Separation of native and truncated forms of poliovirus protease 3C produced in Escherichia coli. Biochem J (1993) 0.75

Articles cited by this

Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65

DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71

Studies on transformation of Escherichia coli with plasmids. J Mol Biol (1983) 116.81

Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene. Proc Natl Acad Sci U S A (1975) 77.46

Oligonucleotide-directed mutagenesis: a simple method using two oligonucleotide primers and a single-stranded DNA template. DNA (1984) 14.55

Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. Proc Natl Acad Sci U S A (1981) 12.00

Further evidence on the formation of poliovirus proteins. J Mol Biol (1970) 9.29

Proteolytic processing of poliovirus polypeptides: antibodies to polypeptide P3-7c inhibit cleavage at glutamine-glycine pairs. Proc Natl Acad Sci U S A (1982) 5.50

Systematic nomenclature of picornavirus proteins. J Virol (1984) 5.26

Translation of encephalomyocarditis virus RNA in vitro yields an active proteolytic processing enzyme. Eur J Biochem (1978) 4.16

The complete nucleotide sequence of a common cold virus: human rhinovirus 14. Nucleic Acids Res (1984) 3.85

Molecular cloning and complete sequence determination of RNA genome of human rhinovirus type 14. Proc Natl Acad Sci U S A (1985) 3.17

Evidence for intramolecular self-cleavage of picornaviral replicase precursors. J Virol (1982) 3.03

Similarity in gene organization and homology between proteins of animal picornaviruses and a plant comovirus suggest common ancestry of these virus families. Nucleic Acids Res (1984) 2.99

Control of ColE1 DNA replication: the rop gene product negatively affects transcription from the replication primer promoter. Proc Natl Acad Sci U S A (1982) 2.56

Homologous sequences in non-structural proteins from cowpea mosaic virus and picornaviruses. EMBO J (1984) 2.35

Protein processing map of poliovirus. J Virol (1984) 2.33

Expression of a cloned gene segment of poliovirus in E. coli: evidence for autocatalytic production of the viral proteinase. Cell (1984) 2.29

Directed mutagenesis of dihydrofolate reductase. Science (1983) 1.88

Kilo-sequencing: an ordered strategy for rapid DNA sequence data acquisition. Nucleic Acids Res (1983) 1.82

Plasmids containing the trp promoters of Escherichia coli and Serratia marcescens and their use in expressing cloned genes. Methods Enzymol (1983) 1.73

Cleavage of poliovirus-specific polypeptide aggregates. J Virol (1973) 1.24

Biologically active protease of foot and mouth disease virus is expressed from cloned viral cDNA in Escherichia coli. Proc Natl Acad Sci U S A (1984) 1.16

A functional hybrid ribosome binding site in tryptophan operon messenger RNA of Escherichia coli. J Mol Biol (1980) 1.13

Articles by these authors

Gene therapy restores vision in a canine model of childhood blindness. Nat Genet (2001) 7.88

HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope. Science (1986) 6.33

Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1991) 4.40

Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc Natl Acad Sci U S A (1995) 3.89

Structure and expression of an ethylene-related mRNA from tomato. Nucleic Acids Res (1987) 3.80

Characterization of the large picornaviral polypeptides produced in the presence of zinc ion. J Virol (1974) 3.36

Early interaction of rhinoviruses with host cells. J Virol (1972) 3.16

Multipotent progenitor cells in the adult dentate gyrus. J Neurobiol (1998) 3.15

Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc Natl Acad Sci U S A (1996) 3.07

Sequencing and identification of a cDNA clone for tomato polygalacturonase. Nucleic Acids Res (1986) 3.00

Zinc ions inhibit replication of rhinoviruses. Nature (1974) 2.92

Naturally occurring and artificially produced components of three rhinoviruses. Virology (1972) 2.84

Human fibroblast interferon: amino acid analysis and amino terminal amino acid sequence. Science (1980) 2.77

Cleavage of viral precursor proteins in vivo and in vitro. J Virol (1972) 2.73

Homology of amino acid sequences of rat liver cathepsins B and H with that of papain. Proc Natl Acad Sci U S A (1983) 2.60

Isolation, characterization, and use of stem cells from the CNS. Annu Rev Neurosci (1995) 2.52

Expression of a truncated tomato polygalacturonase gene inhibits expression of the endogenous gene in transgenic plants. Mol Gen Genet (1990) 2.49

FGF-2-responsive neuronal progenitors reside in proliferative and quiescent regions of the adult rodent brain. Mol Cell Neurosci (1995) 2.45

Molecular characterization of the interferon-induced 15-kDa protein. Molecular cloning and nucleotide and amino acid sequence. J Biol Chem (1986) 2.37

Differentiation of adult hippocampus-derived progenitors into olfactory neurons in vivo. Nature (1996) 2.33

Adult spinal cord stem cells generate neurons after transplantation in the adult dentate gyrus. J Neurosci (2000) 2.24

The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr (2007) 2.21

Neuronal differentiation and morphological integration of hippocampal progenitor cells transplanted to the retina of immature and mature dystrophic rats. Mol Cell Neurosci (2000) 2.07

Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells. Science (1989) 2.03

Polymorphism of the 3' open reading frame of the virus associated with the acquired immune deficiency syndrome, human T-lymphotropic virus type III. Nucleic Acids Res (1985) 2.01

Fibroblast interferon induces synthesis of four proteins in human fibroblast cells. Proc Natl Acad Sci U S A (1979) 2.01

The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity. EMBO J (1991) 1.99

HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41. Biochemistry (1996) 1.91

Long-chain acyl-coenzyme A esters and fatty acids directly link metabolism to K(ATP) channels in the heart. Circ Res (2001) 1.88

Purification and properties of thiol beta-lactamase. A mutant of pBR322 beta-lactamase in which the active site serine has been replaced with cysteine. J Biol Chem (1984) 1.88

Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro. FEBS Lett (1991) 1.78

Interferon-induced proteins. Purification and characterization of a 15,000-dalton protein from human and bovine cells induced by interferon. J Biol Chem (1984) 1.74

Inhibition by zinc of rhinovirus protein cleavage: interaction of zinc with capsid polypeptides. J Virol (1976) 1.71

Isolation and characterization of Hydrogenomonas facilis bacteriophages under heterotrophic growth conditions. J Bacteriol (1966) 1.70

A physician-pharmacist model for the surveillance of blood pressure in the community: a feasibility study. J Hum Hypertens (2001) 1.63

Zonal electrophoresis and isoelectric focusing of proteins and virus particles in density gradients of small volume. Anal Biochem (1974) 1.53

Control and manipulation of gene expression during tomato fruit ripening. Plant Mol Biol (1989) 1.53

A mutation altering the function of a carbohydrate binding protein blocks cell-cell cohesion in developing Dictyostelium discoideum. Nature (1979) 1.53

FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor. Neuron (2000) 1.50

Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain. AIDS Res Hum Retroviruses (1991) 1.50

A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins. Transfusion (2001) 1.49

Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2. Proc Natl Acad Sci U S A (1996) 1.48

Effect of retroviral proteinase inhibitors on Mason-Pfizer monkey virus maturation and transmembrane glycoprotein cleavage. J Virol (1992) 1.46

Voriconazole concentrations and outcome of invasive fungal infections. Clin Microbiol Infect (2009) 1.43

Gestational diseases -- a workshop report. Placenta (2007) 1.41

Fractionation of biologically active and inactive populations of human rhinovirus type 2. Virology (1975) 1.39

Flecainide: what are we measuring? Ther Drug Monit (1990) 1.38

Hyaluronan secretion into the synovial cavity of rabbit knees and comparison with albumin turnover. J Physiol (1997) 1.38

Ataxia telangiectasia mutated is essential during adult neurogenesis. Genes Dev (2001) 1.35

Differentiation of the immortalized adult neuronal progenitor cell line HC2S2 into neurons by regulatable suppression of the v-myc oncogene. Proc Natl Acad Sci U S A (1996) 1.35

V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity. Virology (1992) 1.35

Antibodies from human immunodeficiency virus-infected individuals bind to a short amino acid sequence that elicits neutralizing antibodies in animals. AIDS Res Hum Retroviruses (1989) 1.35

Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC. AIDS Res Hum Retroviruses (1987) 1.27

Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells. Antimicrob Agents Chemother (1992) 1.24

Cleavage of poliovirus-specific polypeptide aggregates. J Virol (1973) 1.24

FGF-2 is sufficient to isolate progenitors found in the adult mammalian spinal cord. Exp Neurol (1997) 1.23

Crystallization and properties of cathepsin B from rat liver. Eur J Biochem (1979) 1.22

Space shuttle flight (STS-90) enhances degradation of rat myosin heavy chain in association with activation of ubiquitin-proteasome pathway. FASEB J (2001) 1.21

Formation of poliovirus RNA polymerase 3D in Escherichia coli by cleavage of fusion proteins expressed from cloned viral cDNA. Virology (1987) 1.20

Primary structure study of rat liver cathepsin B -- a striking resemblance to papain. Biochem Biophys Res Commun (1980) 1.20

Replication of rhinoviruses. Arch Virol (1976) 1.20

Inhibitions by E-64 derivatives of rat liver cathepsin B and cathepsin L in vitro and in vivo. J Biochem (1980) 1.19

Molecular basis of HIV-1 protease drug resistance: structural analysis of mutant proteases complexed with cyclic urea inhibitors. Biochemistry (1997) 1.18

A cell surface alteration in mouse L cells induced by interferon. Biochem Biophys Res Commun (1977) 1.18

Mini-plasmin found in the epithelial cells of bronchioles triggers infection by broad-spectrum influenza A viruses and Sendai virus. Eur J Biochem (2001) 1.18

Personality profile and affective state of patients with inflammatory bowel disease. Gut (1989) 1.18

Molecular pathogenesis of Wilson disease: haplotype analysis, detection of prevalent mutations and genotype-phenotype correlation in Indian patients. Hum Genet (2005) 1.17

Fibroblasts genetically modified to produce nerve growth factor induce robust neuritic ingrowth after grafting to the spinal cord. Exp Neurol (1994) 1.15

Cystatin, a protein inhibitor of cysteine proteases alters viral protein cleavages in infected human cells. Biochem Biophys Res Commun (1985) 1.10

Purification and properties of a new cathepsin from rat liver. J Biochem (1978) 1.09

Two distinct species of human growth hormone-variant mRNA in the human placenta predict the expression of novel growth hormone proteins. J Biol Chem (1988) 1.08

Crystallization of human rhinovirus 1A. Virology (1973) 1.05

Characterization and histologic localization of human growth hormone-variant gene expression in the placenta. J Clin Invest (1989) 1.05

Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant (1992) 1.04

Pharmacokinetics and bioavailability of fluconazole in two groups of males with human immunodeficiency virus (HIV) infection compared with those in a group of males without HIV infection. Antimicrob Agents Chemother (1995) 1.04

Effect of a single amino acid substitution in the V3 domain of the human immunodeficiency virus type 1: generation of revertant viruses to overcome defects in infectivity in specific cell types. J Virol (1994) 1.02

The effects of hybrid ribosome-binding-site variants on the expression of human interferon-beta in Escherichia coli. Gene (1985) 1.00

Cellular proteinases trigger the infectivity of the influenza A and Sendai viruses. Mol Cells (1999) 1.00

Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein. J Virol Methods (2000) 1.00

Heavy users of acute psychiatric beds: randomized controlled trial of enhanced community management in an outer London borough. Psychol Med (2002) 0.99

Mast cell tryptase from pig lungs triggers infection by pneumotropic Sendai and influenza A viruses. Purification and characterization. Eur J Biochem (2000) 0.98

Differential effects of ibuprofen and indomethacin in the regional circulation of the dog. J Pharmacol Exp Ther (1981) 0.98

Molecular cloning and sequencing of cDNA for rat cathepsin L. FEBS Lett (1987) 0.98

Regulation of voltage- and ligand-gated currents in rat hippocampal progenitor cells in vitro. J Neurobiol (1997) 0.97

Thymidine kinase-mediated killing of rat brain tumors. J Neurosurg (1993) 0.97

Separation of a new protease from cathepsin B1 of rat liver lysosomes. FEBS Lett (1976) 0.96

Antibodies reactive with human immunodeficiency virus gag-coded antigens (gag reactive only) are a major cause of enzyme-linked immunosorbent assay reactivity in a blood donor population. J Clin Microbiol (1988) 0.96

Counterion condensation revisited. J Biomol Struct Dyn (1998) 0.95

Proteolytic events in replication of animal viruses. Ann N Y Acad Sci (1980) 0.94

Allosteric sensitivity in hemoglobin at the alpha-subunit N-terminus studied by hydrogen exchange. Biochemistry (1986) 0.94

Actinomycosis of the posterior triangle: a case report and review of the literature. J Laryngol Otol (1997) 0.94

Inhibitory effect of carnosic acid on HIV-1 protease in cell-free assays [corrected]. J Nat Prod (1993) 0.92

Search for a fermiophobic Higgs boson decaying into diphotons in pp[over] collisions at sqrt[s] = 1.96 TeV. Phys Rev Lett (2009) 0.92

Human mucus protease inhibitor in airway fluids is a potential defensive compound against infection with influenza A and Sendai viruses. J Biochem (1997) 0.92

Human growth hormone gene and the highly homologous growth hormone variant gene display different splicing patterns. J Clin Invest (1988) 0.92

Bacteriophage production by autotrophically growing Hydrogenomonas facilis. J Virol (1968) 0.92

Genetic characterization of gram-positive homologs of the XerCD site-specific recombinases. J Mol Microbiol Biotechnol (2000) 0.92

RNA virus gene expression and its control. Annu Rev Microbiol (1972) 0.91